Table 5 Absenteeism, health care use and medication use
Intervention group | Control group | |||
|---|---|---|---|---|
n | n | |||
Absenteeism of school/work (days, previous month) | ||||
T1: median (min-max)a | 0.00 (0–10) | 30 | 0.00(0–10) | 27 |
T2: median (min-max)b | 0.00 (0–20) | 25 | 0.00(0–30) | 24 |
Frequency of health use (whole period) | ||||
Consultation Pediatrician/rheumatologist, median (min-max) | 3 (0–11) | 3.5 (0–28) | ||
Consultation Transition clinical nurse, median (min-max) | 1 (0–7) | 0 (0–10) | ||
Day-care center, median (min-max) | 0 (0–11) | 0 (0–8) | ||
Medication use | ||||
Non Steroid Anti-rheumatic Drug (NSAID) | ||||
T0: n (%) | 12(34.3%) | 35 | 9(28.1%) | 32 |
T1: n (%) | 15(42.9%) | 35 | 10(31.3%) | 32 |
T2: n (%) | 12(34.3%) | 35 | 8(25.0%) | 32 |
Disease Modifying Anti Rheumatic Drug (DMARD) | ||||
T0: n (%) | 19(54.3%) | 35 | 16(50.0%) | 32 |
T1: n (%) | 19(54.3%) | 35 | 15(46.9%) | 32 |
T2: n (%) | 16(45.7%) | 35 | 11(34.4%) | 32 |
Biologicals | ||||
T0: n (%) | 4(11.4%) | 35 | 10(31.3%) | 32 |
T1: n (%) | 7(20%) | 35 | 10(31.3%) | 32 |
T2: n (%) | 7(20%) | 35 | 8(25%) | 32 |
Medication to reduce pain (paracetamol) | ||||
T0: n (%) | 6(17.1%) | 35 | 5(15.6%) | 32 |
T1: n (%) | 2(5.7%) | 35 | 4(12.5%) | 32 |
T2: n (%) | 2(5.7%) | 35 | 5(15.6%) | 32 |